Overview

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to examine the effects of aripiprazole on glucose metabolism in schizophrenic patients without hyperglycemia and diabetes mellitus or any history thereof.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Aripiprazole